T25	Exp 30 55	the inducible degradation
T26	Exp 95 109	the processing
T27	Exp 143 178	The transcription factor NF-kappa B
T28	Exp 188 201	the induction
T29	Exp 240 254	the activation
T30	Exp 308 344	the immunosuppressants cyclosporin A
T31	Exp 392 405	the induction
T32	Exp 409 455	these NF-kappa B-controlled cytokine promoters
T33	Exp 457 459	We
T34	Exp 550 554	that
T35	Exp 633 649	the Rel proteins
T36	Exp 695 717	the nuclear appearance
T37	Exp 555 577	this inhibitory effect
T38	Exp 774 787	the synthesis
T39	Exp 818 843	the inducible degradation
T40	Exp 1025 1027	it
T41	Exp 1089 1094	which
T42	Exp 942 949	neither
T43	Exp 959 973	the processing
T44	Exp 977 1007	the NF-kappa B1 precursor p105
T45	Exp 1040 1062	the C-terminal portion
T46	Exp 1168 1172	that
T47	Exp 1213 1243	the signal-induced degradation
T48	Exp 1303 1317	the processing
T49	Exp 1145 1158	These results
R4	Coref Anaphora:T34 Antecedent:T50
R5	Coref Anaphora:T40 Antecedent:T51
R6	Coref Anaphora:T41 Antecedent:T15
T1	Protein 113 117	p105
T2	Protein 118 129	NF-kappa B1
T3	Protein 650 655	c-Rel
T4	Protein 657 661	RelA
T5	Protein 662 665	p65
T6	Protein 670 681	NF-kappa B1
T7	Protein 682 685	p50
T8	Protein 721 725	RelB
T9	Protein 879 894	I kappa B alpha
T10	Protein 899 913	I kappa B beta
T11	Protein 981 992	NF-kappa B1
T12	Protein 1003 1007	p105
T13	Protein 1011 1014	p50
T14	Protein 1066 1070	p105
T15	Protein 1072 1087	I kappa B gamma
T16	Protein 1114 1118	p105
T17	Protein 1140 1143	p50
T18	Protein 1247 1262	I kappa B alpha
T19	Protein 1267 1281	I kappa B beta
T20	Protein 1321 1332	NF-kappa B1
T21	Protein 1333 1337	p105
T22	Protein 1341 1344	p50
T50	Exp 527 548	primary T lymphocytes
T51	Exp 938 941	CsA
